Takeda Pharmaceutical (TAK) Intangibles (2017 - 2025)
Historic Intangibles for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $22.8 billion.
- Takeda Pharmaceutical's Intangibles fell 1213.74% to $22.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $22.8 billion, marking a year-over-year decrease of 1213.74%. This contributed to the annual value of $23.8 billion for FY2025, which is 1956.91% down from last year.
- Takeda Pharmaceutical's Intangibles amounted to $22.8 billion in Q4 2025, which was down 1213.74% from $22.4 billion recorded in Q3 2025.
- In the past 5 years, Takeda Pharmaceutical's Intangibles registered a high of $36.9 billion during Q1 2021, and its lowest value of $22.4 billion during Q3 2025.
- Its 5-year average for Intangibles is $29.3 billion, with a median of $29.6 billion in 2024.
- In the last 5 years, Takeda Pharmaceutical's Intangibles skyrocketed by 1890849.81% in 2021 and then crashed by 2009.37% in 2022.
- Quarter analysis of 5 years shows Takeda Pharmaceutical's Intangibles stood at $33.4 billion in 2021, then decreased by 20.09% to $26.7 billion in 2022, then rose by 3.98% to $27.7 billion in 2023, then dropped by 6.21% to $26.0 billion in 2024, then fell by 12.14% to $22.8 billion in 2025.
- Its Intangibles was $22.8 billion in Q4 2025, compared to $22.4 billion in Q3 2025 and $23.7 billion in Q2 2025.